Optiscan Imaging Ltd
OIL
Company Profile
Business description
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
Contact
16 Miles Street
Mulgrave
MelbourneVIC3170
AUST: +61 395983333
Sector
Technology
Stock type
Sensitive
Industry
Scientific & Technical Instruments
Fiscal Year End
30 June 2026
Employees
33
Stocks News & Analysis
stocks
ASX listed gold miner under pressure due to lower production
Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks
3 ASX opportunities after earnings season
Uncovering key opportunities following February’s results.
stocks
Oracle earnings: Solid execution secures revenue target and mitigates investor concerns
We raise our fair value estimate for Oracle stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,819.40 | 24.60 | 0.28% |
| CAC 40 | 8,012.77 | 101.24 | 1.28% |
| DAX 40 | 23,742.58 | 178.57 | 0.76% |
| Dow JONES (US) | 46,946.41 | 387.94 | 0.83% |
| FTSE 100 | 10,411.60 | 93.91 | 0.91% |
| HKSE | 25,868.54 | 402.94 | 1.58% |
| NASDAQ | 22,374.18 | 268.82 | 1.22% |
| Nikkei 225 | 53,700.39 | 119.22 | -0.22% |
| NZX 50 Index | 13,182.23 | 17.65 | 0.13% |
| S&P 500 | 6,699.38 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,614.30 | 38.70 | 0.45% |
| SSE Composite Index | 4,049.91 | 34.88 | -0.85% |